PSMA 1007 18F Injection is a fluorine-18 labelled, urea-based radiopharmaceutical tracer designed with high selectivity for the prostate-specific membrane antigen (PSMA). This tracer is primarily utilized… Read more
PSMA 1007 18F Injection is a fluorine-18 labelled, urea-based radiopharmaceutical tracer designed with high selectivity for the prostate-specific membrane antigen (PSMA). This tracer is primarily utilized in nuclear medicine for positron emission tomography (PET) imaging, enabling the precise detection and localization of prostate cancer lesions. The products within this category provide essential reference standards for the active pharmaceutical ingredient, alongside related impurities and stable isotope-labelled compounds. Pharmaceutical laboratories and diagnostic facilities rely on these high-quality materials for critical analytical testing, impurity profiling, and method validation to ensure the accuracy, consistency, and compliance of radiopharmaceutical production. By incorporating these precise reference materials into quality control protocols, researchers can verify the radiochemical purity and stability of the tracer, supporting reliable diagnostic imaging outcomes in clinical settings.